Full-Text Search:
Home|About CNKI|User Service|中文
Add to Favorite Get Latest Update

Effects of puerarin on level of angiotensin II in left cardiac ventricle and its protective effect on left ventricular hypertrophy

HUANG Zhen-gui,CHENG Hui-zhen,ZHANG Nian-bao,DING Bo-ping (Department of Pharmacology,Wannan Medical College & Pharmacology of TCM Grade Three Laboratory,State Administration of Traditional Chinese Medicine of P.R.China,Wuhu 241002,China)  
Objective To explore whether puerarin reversing left ventricular hypertrophy is related to changes on the levels of AngⅡ,ET-1 and NO in plasma and left cardiac ventricle.Methods A rat model of renal hypertension was induced by two-kidney,one-clip.Puerarin was intraperitoneally administered at a concentration of 200,100 and 50 mg/kg(n=8 each)for six weeks respectively.ET-1 and AngⅡ were measured by radioimmunoassay.NO was measured by nitrate reductase.Protein content of the tissue was determined by a Coomassie blue dye-binding assay.Left ventricular mass index (LVMI) calculated by dividing left ventricular mass in milligrams by rat weight in grams.Results Puerarin with three different doses significantly decreased LVMI compared with model group(P0.01 or P0.05).High-and middle-dose puerarin significantly reduced contents of AngⅡ and ET-1(P0.01 or P0.05),but increased that of NO markedly in plasma and left cardiac ventricle (P0.01 or P0.05).Low dose puerarin decreased only the level of Ang Ⅱ in cardiac tissue without obviously changing other biologically active factors mentioned above.Conclusion Puerarin′s protective effect on myocardium is related to its regulatory role for the levels of local myocardial AngⅡ,ET-1 and NO.
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©CNKI All Rights Reserved